The latest price target for Carter's (NYSE:CRI) was reported by UBS on February 26, 2025. The analyst firm set a price target for $49.00 expecting CRI to rise to within 12 months (a possible 15.78% upside). 11 analyst firms have reported ratings in the last year.

The latest analyst rating for Carter's (NYSE:CRI) was provided by UBS, and Carter's maintained their neutral rating.

The last upgrade for Carter's Inc happened on November 12, 2024 when Citigroup raised their price target to $50. Citigroup previously had a sell for Carter's Inc.

The last downgrade for Carter's Inc happened on January 26, 2023 when Wedbush changed their price target from N/A to $78 for Carter's Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Carter's, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Carter's was filed on February 26, 2025 so you should expect the next rating to be made available sometime around February 26, 2026.

While ratings are subjective and will change, the latest Carter's (CRI) rating was a maintained with a price target of $57.00 to $49.00. The current price Carter's (CRI) is trading at is $42.32, which is out of the analyst’s predicted range.